Jack [Analyst]'s questions to QuidelOrtho Corp (QDEL) leadership • Q2 2025
Question
Jack, an analyst from Jefferies on behalf of Tycho Peterson, asked for details on the Point of Care business performance, including the drivers for the Triage business and Sofia instrument results. He also inquired about the company's future exposure to DRG-based panel debundling in China.
Answer
CFO Joseph Busky explained that the Point of Care business was impacted by a 52% decline in COVID-19 sales and a $10 million timing-related decrease in other cardiac revenue, which is expected to reverse in the second half. Sofia flu revenue was flat, as expected for the season. CEO Brian Blaser added that their focus on Stat Labs in China mitigates DRG risk, as these settings are less likely to unbundle test panels.